BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 30, 2007
View Archived Issues
Regeneron Signs Sanofi To Potential $1B Collaboration
Regeneron Pharmaceuticals Inc. and Sanofi-Aventis are collaborating to discover, develop and commercialize human therapeutic antibodies in a cash and stock deal potentially worth $1 billion. (BioWorld Today)
Read More
Axcan Goes Private Through $1.3B TPG Acquisition Deal
Read More
For Cardioprotection, Akt Is Not Sole Actor, Study Finds
Read More
Medgenics' IPO Pulls £3.28M To Advance Biopump Efforts
Read More
MGI Reviews Strategic Options; Stays Mum On Prospective Deals
Read More
Other News To Note
Read More
Clinic Roundup
Read More